No earnings within 2 weeks of this transaction.
| Insider | Malady Kyle |
|---|---|
| Title | EVP and Group CEO-VZ Business |
| Transaction Date | Sep 10, 2026 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Phantom Stock (unitized) |
| Derivative | Yes |
| Direct/Indirect | Indirect |
| Nature of Ownership | By Deferred Compensation Plan |
| Filing Date | Sep 11, 2026 |
| Shares Purchased | 122 |
| Price per Share | $14.26 |
| Total Value | $1,738.45 |
| Shares Owned After | 424,384 |
| Derivative | Derivative |
| Accession Number | 0001760581-26-000054 |
| Document | View SEC Filing |